Ikena Oncology, Inc. — Form D
Ikena Oncology, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-18. The offering totals $75.0M. Industry: Biotechnology.
Offering
- Filed: 2025-07-18
- Form: D
- Accession: 0001470831-25-000095
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $75.0M
- Remaining: $75.0M
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-552269
Issuer
- Name: Ikena Oncology, Inc.
- CIK: 0001835579
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 645 Summer Street, Suite 101, BOSTON, MA, 02210
- Phone: 857-273-8343
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| David Bonita | Director | New York, NY |
| Iain Dukes | Director | Cambridge, MA |
| Jean-Francois Formela | Director | Cambridge, MA |
| Owen Hughes | Director | Sudbury, MA |
| Maria Koehler | Director | Boston, MA |
| Mark Manfredi | Director | Boston, MA |
| Otello Stampacchia | Director | Boston, MA |
| Richard Wooster | Director | Boston, MA |
| Jeffrey Ecsedy | Executive Officer | Boston, MA |
| Mark Manfredi | Executive Officer | Boston, MA |
| Jotin Marango | Executive Officer | Boston, MA |
| Maria D Koehler | Director | Boston, MA |
| Sergio Santillana | Executive Officer | Boston, MA |
| Richard D Wooster | Director | Boston, MA |
| Michelle Zhang | Executive Officer | Boston, MA |
| Iain D Dukes | Director | Boston, MA |
| Otello D Stampacchia | Director | Boston, MA |
| Jean-Francois D Formela | Director | Boston, MA |
Other filings by this issuer (1)
More